Exosomes – tiny biological nanoparticles which transfer information between cells – offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded.
Areas which could benefit include cancer treatment and regenerative medicine, say Dr Steven Conlan from Swansea University, Dr Mauro Ferrari of Houston Methodist Research Institute in Texas, and Dr Inês Mendes Pinto from the International Iberian Nanotechnology Laboratory in Portugal. Their commissioned paper, Exosomes as Reconfigurable Therapeutic Systems, is published today by Cell Press in Trends in Molecular Medicine.
Exosomes are particles produced by all cells in the body and are from 30-130 nanometres in size – a nanometre is one-billionth of a metre. They act as biological signalling systems, communicating between cells, carrying proteins, lipids, DNA and RNA. They drive biological processes, from modulating gene expression to transmitting information through breast milk.
Though discovered in 1983, the full potential of exosomes is only gradually being revealed. The researchers show that the nanoparticles’ possible medical benefits fall into three broad categories:
- Detecting disease – by acting as disease-specific biomarkers
- Activating immune responses to boost immunity
- Treating diseases – serving as the vehicle for drugs, for example bearing cancer therapies as their payload, to target tumours
One of the most useful properties of exosomes is that they are able to cross barriers such as the plasma membrane of cells, or the blood/brain barrier. This makes them well-suited to delivering therapeutic molecules in a very targeted way.
The potential benefits of exosomes can be seen in the wide range of research projects – cited in the paper – already either completed or under way, in areas such as:
- Improved testing for prostate cancer
- A small-cell lung cancer trial
- Stem cell-derived exosomes strengthening heart muscles
- Regeneration of muscle and tissue
The team caution that there is more to do before research into exosomes translates into new techniques and treatments. Side-effects need to be considered, and a standardised approach to isolating, characterising and storing exosomes will need to be developed.
Researchers will also need to ensure that the properties of exosomes do not end up causing harm: for example they can transfer drug resistance and pacify the immune system.
Nevertheless, the potential is very clear, with the team describing exosomes as “increasingly promising”.
Professor Steve Conlan of Swansea University Medical School, one of the authors of the paper, said:
“Our survey of research into exosomes shows clearly that they offer enormous potential as a basis for detecting and treating disease.
Further studies are necessary to turn this research into clinical outcomes, but researchers and funders should be very encouraged by our findings. Our own research in Swansea is investigating the use of exosomes and exosome-like synthetic nanoparticles in combatting ovarian and endometrial cancer.
Progress in this field depends on partnership. As the authorship of our own paper illustrates, researchers in different countries are increasingly working together in nanohealth. Swansea University has wider links with Houston and Portuguese based researchers in the field.
It’s also important to build partnerships outside academia, in particular with government and companies in this fast-growing sector.”
The Latest on: Exosomes
- Nanotechnology based drug delivery systems for nanomedicine on September 18, 2018 at 5:51 am
Exosomes are the most promising next generation ‘natural’ nanovehicles for targeted drug and gene delivery. These are nano-sized vesicles (with diameter 40-200 nm) derived from patients’ own healthy c... […]
- Aethlon Medical Receives National Cancer Institute Award on September 18, 2018 at 5:46 am
The title of this SBIR Phase I grant is "The Hemopurifier Device for Targeted Removal of Breast Cancer Exosomes from the Blood Circulation." The Aethlon Hemopurifier is a first-in-class ... […]
- Exosomes Market Leading Vendors Dynamic Growth with Market Price Analysis and Value Chain Features By 2023 on September 17, 2018 at 10:41 pm
Industry Outlook and Trend Analysis: The Exosomes Market was worth USD 2.26 million in 2014 and is expected to reach approximately USD 10.61 million by 2023, while registering itself at a compound ... […]
- Exosomes Market By Workflow, By Biomolecule Type And Application- Global Industry Analysis And Forecast To 2023 on September 13, 2018 at 12:29 am
The Exosomes Market was worth USD 2.26 million in 2014 and is expected to reach approximately USD 10.61 million by 2023, while registering itself at a compound annual growth rate (CAGR) of 18.77% duri... […]
- Researchers invent novel RNA nanotech to decorate exosomes for effective cancer therapy on December 10, 2017 at 4:00 pm
A new study shows that attaching antibody-like RNA nanoparticles to microvesicles can deliver effective RNA therapeutics such as small interfering RNA (siRNA) specifically to cancer cells. Researchers ... […]
- Exosomes are the missing link to insulin resistance in diabetes on September 21, 2017 at 12:15 pm
An electron microscopy image shows the morphology of the bright and round shape vesicles known as exosomes. Credit: UC San Diego Health Chronic tissue inflammation resulting from obesity is an underly... […]
- New approach for the capture of tumor-derived exosomes from a prostate cancer cell line on February 20, 2017 at 4:00 pm
Figure a shows captured exosomes on ligand-baited nanosprings, the exosomes are indicated by the arrows. Figure b shows a TEM image of captured exosomes following negative staining with phosphotungsti... […]
- Scientists find that stem cell exosomes promote survival of retinal ganglion cells in rats on January 26, 2017 at 9:10 pm
A new study in rats shows that stem cell secretions, called exosomes, appear to protect cells in the retina, the light-sensitive tissue in the back of the eye. The findings, published in Stem Cells Tr... […]
- Analysis of extracellular vesicles including exosomes by imaging flow cytometry on January 25, 2017 at 9:52 am
This webinar was originally scheduled for broadcast on June 8, but was postponed due to technical issues. Extracellular vesicles (EVs) such as exosomes (70 nm – 160 nm in diameter) and microvesicles ( ... […]
- Are Exosomes the Next PD-1 in Cancer Research? on April 30, 2014 at 7:03 am
Whitefish, MT / April 30, 2014 / PD-1, or programmed death protein 1, is certainly a hot button in the field of oncology, with the new immune checkpoint inhibitors pegged by many as part of a wave of ... […]
via Google News and Bing News